Navigating Deuruxolitinib#39;s road: HSBC and Nomura weigh in on Sun Pharma#39;s outlook

HSBC and Nomura maintain buy ratings, with HSBC increasing target price to Rs 1275 ( 13.5% from earlier) and Nomura to Rs 1313 (from Rs 1138).

Top 100 Best Sellers

Read More

​ HSBC and Nomura maintain buy ratings, with HSBC increasing target price to Rs 1275 ( 13.5% from earlier) and Nomura to Rs 1313 (from Rs 1138). HSBC and Nomura maintain buy ratings, with HSBC increasing target price to Rs 1275 ( 13.5% from earlier) and Nomura to Rs 1313 (from Rs 1138).  Moneycontrol Latest News Read More